PD-1 blockade and allogeneic hematopoietic stem cell transplantation in Hodgkin lymphoma, a matter of time: a national study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire

Haematologica. 2024 Oct 1;109(10):3373-3378. doi: 10.3324/haematol.2024.284968.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Female
  • France / epidemiology
  • Hematopoietic Stem Cell Transplantation* / methods
  • Hodgkin Disease* / diagnosis
  • Hodgkin Disease* / therapy
  • Humans
  • Immune Checkpoint Inhibitors / therapeutic use
  • Male
  • Middle Aged
  • Programmed Cell Death 1 Receptor* / antagonists & inhibitors
  • Transplantation, Homologous
  • Treatment Outcome

Substances

  • Programmed Cell Death 1 Receptor
  • Immune Checkpoint Inhibitors
  • PDCD1 protein, human